CNY 5.4
(1.12%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 170.15 Million CNY | -1.64% |
2022 | 158.42 Million CNY | -43.05% |
2021 | 517.64 Million CNY | 26.86% |
2020 | 429.38 Million CNY | 7.36% |
2019 | 401.16 Million CNY | 44.9% |
2018 | 281.24 Million CNY | 27.69% |
2017 | 225.12 Million CNY | 170.08% |
2016 | 80.85 Million CNY | 43.43% |
2015 | 50.7 Million CNY | -13.15% |
2014 | 62.52 Million CNY | 3.7% |
2013 | 58.84 Million CNY | 12.88% |
2012 | 55.05 Million CNY | 45.34% |
2011 | 36.5 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 28.96 Million CNY | -41.66% |
2024 Q2 | 61.26 Million CNY | 208.17% |
2024 Q1 | 41.78 Million CNY | 203.04% |
2023 Q1 | 36.37 Million CNY | 11875.98% |
2023 Q3 | 107.62 Million CNY | 131.67% |
2023 Q4 | 36.2 Million CNY | -66.36% |
2023 FY | - CNY | -1.64% |
2023 Q2 | 46.45 Million CNY | 27.72% |
2022 Q3 | 93.92 Million CNY | 108.17% |
2022 FY | - CNY | -43.05% |
2022 Q4 | -308.89 Thousand CNY | -100.33% |
2022 Q2 | 45.12 Million CNY | -64.35% |
2022 Q1 | 126.56 Million CNY | -44.68% |
2021 Q2 | 98.65 Million CNY | -5.63% |
2021 Q3 | 116.54 Million CNY | 18.14% |
2021 Q4 | 228.8 Million CNY | 96.33% |
2021 FY | - CNY | 26.86% |
2021 Q1 | 104.53 Million CNY | -44.35% |
2020 Q2 | 66.31 Million CNY | -23.84% |
2020 Q3 | 95.15 Million CNY | 43.49% |
2020 Q1 | 87.07 Million CNY | -47.75% |
2020 FY | - CNY | 7.36% |
2020 Q4 | 187.83 Million CNY | 97.41% |
2019 Q2 | 92.97 Million CNY | 15.45% |
2019 Q1 | 80.53 Million CNY | -36.75% |
2019 FY | - CNY | 44.9% |
2019 Q4 | 166.65 Million CNY | 111.51% |
2019 Q3 | 78.79 Million CNY | -15.25% |
2018 Q3 | 60.24 Million CNY | 100.26% |
2018 Q4 | 127.33 Million CNY | 111.36% |
2018 FY | - CNY | 27.69% |
2018 Q1 | 68.42 Million CNY | -42.83% |
2018 Q2 | 30.08 Million CNY | -56.03% |
2017 Q4 | 119.68 Million CNY | 277.43% |
2017 Q3 | 31.71 Million CNY | 14.02% |
2017 Q1 | 30.99 Million CNY | -60.25% |
2017 Q2 | 27.81 Million CNY | -10.26% |
2017 FY | - CNY | 170.08% |
2016 FY | - CNY | 43.43% |
2016 Q3 | 19.76 Million CNY | 1279.81% |
2016 Q1 | -13.94 Million CNY | -152.4% |
2016 Q2 | -1.67 Million CNY | 87.99% |
2016 Q4 | 77.97 Million CNY | 294.57% |
2015 Q4 | 26.6 Million CNY | 44.74% |
2015 Q3 | 18.38 Million CNY | 40.64% |
2015 Q2 | 13.07 Million CNY | 830.84% |
2015 Q1 | -1.78 Million CNY | -103.87% |
2015 FY | - CNY | -13.15% |
2014 Q4 | 46.22 Million CNY | 191.45% |
2014 Q3 | 15.86 Million CNY | 192.52% |
2014 Q2 | 5.42 Million CNY | 504.42% |
2014 Q1 | -1.34 Million CNY | 0.0% |
2014 FY | - CNY | 3.7% |
2013 FY | - CNY | 12.88% |
2012 FY | - CNY | 45.34% |
2011 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Vanfund Urban Investment and Development Co., Ltd. | 9.23 Million CNY | -1742.697% |
Winning Health Technology Group Co., Ltd. | 617.04 Million CNY | 72.425% |
Longmaster Information & Technology Co., Ltd. | 108.08 Million CNY | -57.42% |